PRESS RELEASE published on 02/24/2026 at 18:45, 8 months ago Inside Information / News release on accounts, results
BRIEF published on 01/09/2026 at 08:27, 9 months 16 days ago Verallia's liquidity contract review for the second half of 2025 Liquidity Contract Transactions Euronext Financial Markets Verallia
BRIEF published on 01/09/2026 at 08:20, 9 months 16 days ago Verallia's liquidity contract performance for the second half of 2025 Euronext Paris Liquidity Contract Transactions Sotck Exchange Verallia
BRIEF published on 10/22/2025 at 18:50, 1 year ago Verallia's Q3 Results Show Volume Growth Amidst Profitability Challenges Sustainability Profitability Q3 Results Volume Growth Verallia
PRESS RELEASE published on 10/22/2025 at 18:45, 1 year ago Quarterly financial reporting / Third quarter financial report Verallia's 2025 Q3 results show continued volume growth but lower profitability, prompting an adjustment to the 2025 outlook, with revenue at €846 million and adjusted EBITDA at €181 million Revenue Profitability Q3 Results Volume Growth Verallia
BRIEF published on 08/26/2025 at 18:35, 1 year 1 month ago Verallia Concludes Put Option Exercise for 2028 and 2031 Notes Financial Strategy Put Option Verallia Notes Redemption BWGI
PRESS RELEASE published on 08/26/2025 at 18:30, 1 year 1 month ago Inside Information / Other news releases Verallia announces redemption results of 2028 and 2031 Notes following Change of Control event. Noteholders exercise Put Option for total nominal amounts. Financing through bridge loan and plans for refinancing disclosed Change Of Control Redemption Verallia 2031 Notes 2028 Notes
BRIEF published on 08/14/2025 at 18:35, 1 year 2 months ago Verallia Reports on BWGI's Voluntary Public Tender Offer Results Share Capital Voting Rights Tender Offer Verallia BWGI
PRESS RELEASE published on 08/14/2025 at 18:30, 1 year 2 months ago News releases during takeover bids / Takeover bids Other news releases Verallia announces BWGI's successful completion of voluntary public tender offer, acquiring 6.74% of share capital and 5.72% of voting rights, reaching 77.05% and 69.15% respectively. Settlement on August 20, 2025 Share Capital Voting Rights Tender Offer Verallia BWGI
BRIEF published on 08/12/2025 at 16:01, 1 year 2 months ago JP Morgan Crosses Thresholds in VERALLIA Actions JP Morgan Crossing Verallia Assignment
Published on 10/24/2026 at 00:04, 1 day 10 hours ago Sparta Capital Ltd. Provides Corporate Update on Reinstatement Review, Financial Statement Corrections and Governance Matters
Published on 10/23/2026 at 23:30, 1 day 10 hours ago Algo Grande Commissions Independent NI 43-101 Update to Capture First Year of Progress at Adelita
Published on 10/23/2026 at 21:55, 1 day 12 hours ago Apex Closes Offering and Completes NASDAQ Listing
Published on 10/23/2026 at 16:00, 1 day 18 hours ago Leggett Dynamics's Mid-Class Massage System Wins Gasgoo's Best Technical Practice Award
Published on 10/24/2026 at 23:44, 11 hours 36 minutes ago EQS-Adhoc: HomeToGo SE: Unauthorized data exfiltration at subsidiary SECRA Bookings GmbH
Published on 10/24/2026 at 14:15, 21 hours 6 minutes ago Winners of the 2026 INPD Awards Announced, C-Beauty Takes Home Multiple Prestigious Honors
Published on 10/24/2026 at 06:30, 1 day 3 hours ago AI and EV Boom Draws $690 Million in Advanced Materials Investment Plans to Thailand
Published on 10/23/2026 at 18:55, 1 day 15 hours ago Qatar's Years of Culture Initiative Announces Partner Countries Through 2030
Published on 10/23/2026 at 18:00, 1 day 16 hours ago BIOSYNEX SA: CHEMBIO DIAGNOSTIC SYSTEMS AWARDED $5.7 MILLION TO ADVANCE DPP® BIOTHREAT PANEL
Published on 10/23/2026 at 20:33, 1 day 13 hours ago Disclosure of transactions in own shares from October 19 to October 23, 2026
Published on 10/23/2026 at 17:45, 1 day 16 hours ago Imerys-10-2026-information-share-capital-and-voting-rights-as-of-30-September-2026
Published on 10/22/2026 at 18:00, 2 days 16 hours ago THERMADOR GROUPE : Completion of the share buy-back programme launched in August
Published on 10/22/2026 at 18:00, 2 days 16 hours ago bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics
